GoLiver Therapeutics
Nantes · Founded 2017
About GoLiver Therapeutics
GoLiver Therapeutics is a spin-off of Inserm and the University of Nantes (CRTI UMR1064, ITUN, University Hospital of Nantes), specializing in the development of Innovative Therapy Drugs (MTI) to meet an urgent medical need not met in transplantation.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Last round: Grant (Mar 2021)
- Website: https://golivertx.com/
- Phone: +33 0 782721251
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/goliver-therapeutics-135563 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.